NVAX : Novavax stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis
| year | Average | Low | High | Change from close on 2022-09-26 |
|---|---|---|---|---|
| 2022 | $17.58 | $16.6 | $18.42 | -6.86% |
| 2023 | $15.49 | $14.52 | $16.45 | -17.9% |
| 2024 | $23.48 | $17.47 | $26.9 | 24.42% |
| 2025 | $25.07 | $22.89 | $26.86 | 32.88% |
| 2026 | $17.83 | $13.29 | $22.27 | -5.52% |
| 2027 | $9.65 | $8.06 | $12.58 | -48.85% |
| 2028 | $13.33 | $8.42 | $20.73 | -29.38% |
| 2029 | $31.08 | $22.01 | $46.89 | 64.69% |
| 2030 | $102.41 | $53.17 | $140.92 | 442.73% |
| 2031 | $122.74 | $102.67 | $143.61 | 550.47% |
| 2032 | $143.26 | $103.66 | $193.79 | 659.19% |
The 3 Wall Street analysts offering Novavax stock forecast in the last 6 months have average price target of
$160.33 with a high forecast of $203.0 and a low forecast of $110.0.
The average Novavax stock forecast represents a 749.66%
increase from the last price of $18.8700008392334.
From AI system, total return is 2451.47% from 4062 forecasts.
For Novavax stock forecast for 2022, 3 predictions are offered for each month of 2022 with average Novavax stock
forecast of $17.58, a high forecast of $18.42, and a low forecast of $16.6.
The average Novavax stock forecast 2022 represents a -6.86%
decrease from the last price of $18.8700008392334.
For Novavax stock forecast for 2023, 12 predictions are offered for each month of 2023 with average Novavax stock
forecast of $15.49, a high forecast of $16.45, and a low forecast of $14.52.
The average Novavax stock forecast 2023 represents a -17.9%
decrease from the last price of $18.8700008392334.
For Novavax stock forecast for 2025, 12 predictions are offered for each month of 2025 with average Novavax stock
forecast of $25.07, a high forecast of $26.86, and a low forecast of $22.89.
The average Novavax stock forecast 2025 represents a 32.88%
increase from the last price of $18.8700008392334.
For Novavax stock forecast for 2027 (5 year), 12 predictions are offered for each month of 2027 with average Novavax stock
forecast of $9.65, a high forecast of $12.58, and a low forecast of $8.06.
The average Novavax stock forecast 2027 represents a -48.85%
decrease from the last price of $18.8700008392334.
For Novavax stock forecast for 2030, 12 predictions are offered for each month of 2030 with average Novavax stock
forecast of $102.41, a high forecast of $140.92, and a low forecast of $53.17.
The average Novavax stock forecast 2030 represents a 442.73%
increase from the last price of $18.8700008392334.
For Novavax stock forecast for 2032 (10 year), 9 predictions are offered for each month of 2032 with average Novavax stock
forecast of $143.26, a high forecast of $193.79, and a low forecast of $103.66.
The average Novavax stock forecast 2032 represents a 659.19%
increase from the last price of $18.8700008392334.
Please, see more forecasts below.
NVAX : Novavax stock forecast by Wall Street Analysts
The average Novavax stock forecast from last 6 month is $160.33, and this show a -11.91% decrease in average from the prior price target of the each prediction. Also, this average forecast of $160.33 represents a -15.02% decrease from the past average forecast of $188.67, 6 months ago from 3 wall street analysts.
Novavax stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2022-09-27 | $20.74 | 9.91% |
| 2022-09-28 | $21.62 | 4.24% |
| 2022-09-29 | $20.36 | -5.83% |
| 2022-09-30 | $21.13 | 3.80% |
| 2022-10-03 | $20.51 | -2.95% |
NVAX : Long term Novavax stock forecast for 2022, 2023 (1 year) - 2025 - 2027 (5 year) - 2030, and 2032 (10 year)
Forecast for 2022 Oct. is $18.42 , for 2023 Sep. is $15.73 , for 2026 Sep. is $15.68 , for 2027 Sep. is $8.16 , for 2031 Sep. is $108.16 , and for 2032 Sep. is $193.79.
NVAX : Novavax stock forecast for 2022
| Date | Price Target | Change |
|---|---|---|
| 2022 Oct. | $18.42 | -2.39% |
| 2022 Nov. | $17.71 | -3.86% |
| 2022 Dec. | $16.60 | -6.25% |
NVAX : Novavax stock forecast for 2023
| Date | Price Target | Change |
|---|---|---|
| 2023 Jan. | $16.22 | -2.28% |
| 2023 Feb. | $15.64 | -3.59% |
| 2023 Mar. | $15.03 | -3.91% |
| 2023 Apr. | $14.52 | -3.40% |
| 2023 May. | $15.08 | 3.89% |
| 2023 Jun. | $15.18 | 0.64% |
| 2023 Jul. | $15.46 | 1.88% |
| 2023 Aug. | $15.78 | 2.03% |
| 2023 Sep. | $15.73 | -0.29% |
| 2023 Oct. | $15.28 | -2.91% |
| 2023 Nov. | $15.54 | 1.71% |
| 2023 Dec. | $16.45 | 5.87% |
NVAX : Novavax stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Jan. | $17.47 | 6.21% |
| 2024 Feb. | $18.55 | 6.18% |
| 2024 Mar. | $19.81 | 6.77% |
| 2024 Apr. | $21.40 | 8.04% |
| 2024 May. | $22.98 | 7.39% |
| 2024 Jun. | $24.26 | 5.57% |
| 2024 Jul. | $25.13 | 3.58% |
| 2024 Aug. | $25.74 | 2.42% |
| 2024 Sep. | $26.19 | 1.75% |
| 2024 Oct. | $26.53 | 1.28% |
| 2024 Nov. | $26.77 | 0.94% |
| 2024 Dec. | $26.90 | 0.46% |
NVAX : Novavax stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $26.86 | -0.12% |
| 2025 Feb. | $26.66 | -0.77% |
| 2025 Mar. | $26.34 | -1.20% |
| 2025 Apr. | $26.00 | -1.28% |
| 2025 May. | $25.63 | -1.41% |
| 2025 Jun. | $25.29 | -1.35% |
| 2025 Jul. | $24.97 | -1.27% |
| 2025 Aug. | $24.64 | -1.29% |
| 2025 Sep. | $24.29 | -1.42% |
| 2025 Oct. | $23.90 | -1.64% |
| 2025 Nov. | $23.43 | -1.95% |
| 2025 Dec. | $22.89 | -2.31% |
NVAX : Novavax stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $22.27 | -2.71% |
| 2026 Feb. | $21.58 | -3.11% |
| 2026 Mar. | $20.82 | -3.51% |
| 2026 Apr. | $20.01 | -3.89% |
| 2026 May. | $19.16 | -4.23% |
| 2026 Jun. | $18.29 | -4.54% |
| 2026 Jul. | $17.41 | -4.81% |
| 2026 Aug. | $16.54 | -5.04% |
| 2026 Sep. | $15.68 | -5.20% |
| 2026 Oct. | $14.84 | -5.32% |
| 2026 Nov. | $14.04 | -5.38% |
| 2026 Dec. | $13.29 | -5.38% |
NVAX : Novavax stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $12.58 | -5.35% |
| 2027 Feb. | $11.91 | -5.31% |
| 2027 Mar. | $11.28 | -5.28% |
| 2027 Apr. | $10.68 | -5.36% |
| 2027 May. | $10.08 | -5.62% |
| 2027 Jun. | $9.47 | -6.04% |
| 2027 Jul. | $8.88 | -6.16% |
| 2027 Aug. | $8.43 | -5.13% |
| 2027 Sep. | $8.16 | -3.23% |
| 2027 Oct. | $8.06 | -1.20% |
| 2027 Nov. | $8.09 | 0.39% |
| 2027 Dec. | $8.22 | 1.55% |
NVAX : Novavax stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $8.42 | 2.49% |
| 2028 Feb. | $8.70 | 3.34% |
| 2028 Mar. | $9.07 | 4.25% |
| 2028 Apr. | $9.56 | 5.40% |
| 2028 May. | $10.27 | 7.39% |
| 2028 Jun. | $11.39 | 10.93% |
| 2028 Jul. | $13.05 | 14.62% |
| 2028 Aug. | $14.88 | 13.95% |
| 2028 Sep. | $16.50 | 10.90% |
| 2028 Oct. | $17.97 | 8.93% |
| 2028 Nov. | $19.38 | 7.83% |
| 2028 Dec. | $20.73 | 6.97% |
NVAX : Novavax stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $22.01 | 6.17% |
| 2029 Feb. | $23.21 | 5.45% |
| 2029 Mar. | $24.35 | 4.93% |
| 2029 Apr. | $25.49 | 4.71% |
| 2029 May. | $26.73 | 4.86% |
| 2029 Jun. | $28.16 | 5.35% |
| 2029 Jul. | $29.87 | 6.08% |
| 2029 Aug. | $31.97 | 7.01% |
| 2029 Sep. | $34.57 | 8.13% |
| 2029 Oct. | $37.81 | 9.39% |
| 2029 Nov. | $41.86 | 10.70% |
| 2029 Dec. | $46.89 | 12.01% |
NVAX : Novavax stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $53.17 | 13.40% |
| 2030 Feb. | $61.06 | 14.83% |
| 2030 Mar. | $70.68 | 15.75% |
| 2030 Apr. | $81.49 | 15.30% |
| 2030 May. | $92.38 | 13.37% |
| 2030 Jun. | $102.41 | 10.86% |
| 2030 Jul. | $111.30 | 8.68% |
| 2030 Aug. | $119.23 | 7.13% |
| 2030 Sep. | $126.34 | 5.96% |
| 2030 Oct. | $132.52 | 4.89% |
| 2030 Nov. | $137.46 | 3.73% |
| 2030 Dec. | $140.92 | 2.52% |
NVAX : Novavax stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $142.94 | 1.43% |
| 2031 Feb. | $143.61 | 0.47% |
| 2031 Mar. | $142.58 | -0.72% |
| 2031 Apr. | $138.64 | -2.77% |
| 2031 May. | $132.44 | -4.47% |
| 2031 Jun. | $124.88 | -5.71% |
| 2031 Jul. | $116.48 | -6.73% |
| 2031 Aug. | $110.97 | -4.74% |
| 2031 Sep. | $108.16 | -2.53% |
| 2031 Oct. | $105.87 | -2.12% |
| 2031 Nov. | $103.67 | -2.07% |
| 2031 Dec. | $102.67 | -0.96% |
NVAX : Novavax stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $103.66 | 0.96% |
| 2032 Feb. | $106.82 | 3.05% |
| 2032 Mar. | $112.51 | 5.33% |
| 2032 Apr. | $121.73 | 8.19% |
| 2032 May. | $136.42 | 12.07% |
| 2032 Jun. | $155.96 | 14.33% |
| 2032 Jul. | $173.34 | 11.14% |
| 2032 Aug. | $185.13 | 6.80% |
| 2032 Sep. | $193.79 | 4.68% |
Financial Data for Novavax stock
Frequently Asked Questions about Novavax stock forecast
Is Novavax a good long term stock?
From Novavax stock forecast , Novavax (NVAX) stock cannot be a good investment choice. According to AI Pickup, the Novavax stock price forecast for 2022 Oct. is $18.4187359789535 From Novavax stock forecast , Novavax (NVAX) stock cannot be a good investment choice. According to AI Pickup, the Novavax stock price forecast for 2023 Sep. is $15.733024762223 From Novavax stock forecast , Novavax (NVAX) stock cannot be a good investment choice. According to AI Pickup, the Novavax stock price forecast for 2026 Sep. is $15.6753080163821 From Novavax stock forecast , Novavax (NVAX) stock cannot be a good investment choice. According to AI Pickup, the Novavax stock price forecast for 2027 Sep. is $8.15621089049801 From Novavax stock forecast , Novavax (NVAX) stock can be a good investment choice. According to AI Pickup, the Novavax stock price forecast for 2031 Sep. is $108.16408074854 From Novavax stock forecast , Novavax (NVAX) stock can be a good investment choice. According to AI Pickup, the Novavax stock price forecast for 2032 Sep. is $193.788522341153
Is Novavax stock overvalued?
Novavax (NVAX) stock is expected to go DOWN . Therefore, AI Pickup would say that Novavax (NVAX) stock is overvalued.
Will Novavax stock price go up?
No. The Novavax stock price forecast for 2023 Sep. is $15.733024762223
Is Novavax stock a good buy now?
Since closing price on 2022-09-26 is $18.8700008392334 and forecast for 2023 Sep. is $15.73, Novavax stock is not a good 1 year investment.